Abattis Bioceuticals Corp. (ATTBF)
Develops cannabis-derived health products and medicines for pain, inflammation, and wellness.
$0.00+0.00%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+200.0%
The outlook
ATTBF is trading near its 52-week high and above both its 50- and 200-day moving averages, suggesting positive near-term momentum. The stock shows a bullish technical setup based on current price positioning. Analyst coverage appears limited for this micro-cap security.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range100% of the way from its 52-week low to high
Market cap
$14,334
52-wk high
$0.00
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—